Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer

PURPOSE: Previous retrospective studies suggest that anaplastic lymphoma kinase (ALK) mutation-positive (ALK+) non-small cell lung cancer (NSCLC) patients are sensitive to pemetrexed. To determine its efficacy, we retrospectively evaluated clinical outcomes of pemetrexed-based chemotherapy in patien...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Yonsei Med J
Prif Awduron: Jo, Jaemin, Kim, Se Hyun, Kim, Yu Jung, Lee, Juhyun, Kim, Miso, Keam, Bhumsuk, Kim, Tae Min, Kim, Dong-Wan, Heo, Dae Seog, Chung, Jin-Haeng, Jeon, Yoon Kyung, Lee, Jong Seok
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Yonsei University College of Medicine 2018
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5823821/
https://ncbi.nlm.nih.gov/pubmed/29436187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2018.59.2.202
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg